Skip to main content

Patient Registry Software Market Trends, Significant Growth, Synopsis and Development Brief 2020

Patient Registry Software Market is Expected to Rise at a CAGR of 11.08% during 2019 – 2025 :
Pune, India, October 2019, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Patient Registry Software Market.
Market Highlights
The Global Patient Registry Software Market is expected to register a CAGR of 11.08
during the forecast period with a market value of USD 1,998.83 Million till 2025.
Patient registry software is an organized system that utilizes observational study methods for collecting clinical as well as non-clinical patient data for evaluation of specified outcomes for a population that is defined by a particular disease, condition, or exposure, and that serves a predetermined clinical, scientific, or policy purposes.
The high adoption rate of electronic health records and increasing use of patient registry data for post-marketing surveillance is anticipated to drive the market growth of the global patient registry software market. However, privacy and data security-related concerns are expected to restrict the market growth.
Segment Analysis
The Global Patient Registry Software Market has been divided based on the type of registry, functionality, deployment model, and end-user. The market, based on type of registry, has been segregated into health service registries, product registries, disease registries, and others. Based on functionality, the patient registry software market has been divided into health information exchange (HIE), population health management (PHM), patient care management, and others. On the basis of deployment model, it is bifurcated into cloud and on-premise cloud. The global patient registry software market, based on end-user, has been categorized as hospitals and clinics, government organizations & research centers and others.
Regional Analysis
The Global Patient Registry Software Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to hold the largest share of the global patient registry software market during the assessment period. well-established EHRs and development of digital infrastructure in healthcare are likely to support the dominance of the Americas during the forecast period. The Europe market established substantial growth in the market due to the rising government initiatives for the implementation of patient registries in this region. Asia-Pacific is estimated to be the fastest-growing region in the global market due to the reduction of healthcare costs and various initiatives taken by the government for the reduction of the rising pressure to improve the quality of care fueling the growth of the patient registry software market in the region. The patient registry software market in the Middle East & Africa is expected to witness gradual growth due to the increasing awareness about patient registry software.
Access Report Details @ https://www.marketresearchfuture.com/reports/patient-registry-software-market-6917
Market Players
MRFR recognizes the following companies as the Key Players in the Global Patient Registry Software Market—
IQVIA(US)., Phamax (Europe), McKesson Corporation (US), Open Text Corporation (Canada), Evado Pty. Ltd(Australia), ArborMetrix(US), IBM(US), Optum, Inc.( US), LUMEDX(US), IFA SYSTEMS(Germany), Dacima Software Inc(Canada)
and Others.
Key Findings of the Study
  • TheGlobal Patient Registry Software Market
    is estimated to grow at USD 1,998.83 Million by 2025 at a CAGR of 11.08% during the assessment period.
  • The Americas accounted for the largest share of the global market due to the presence of key market players and the development of digital infrastructure in healthcare attributed to the growth of patient registry software in the US and Canada.
  • Based on functionality, the population health management (PHM) segment accounted for the largest market share of41% in 2018.
  • Based on the deployment model, the on-premise segment accounted for the largest market share of56% in 2018
    .
  • On the basis of end-user, the hospitals and clinics segment accounted for the largest market share of55% in 2018
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...

Middle East And Africa Pediatric Healthcare Market Development Research with Forthcoming Opportunities and Challenges

  Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Avail a Free Sample@  https://www.marketresearchfuture.com/...